Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
FLAC was delisted on the 22nd of November, 2022.
41 hedge funds and large institutions have $63.6M invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 1 reducing their positions, and 3 closing their positions.
800% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
27% more capital invested
Capital invested by funds: $50M → $63.6M (+$13.6M)
17% more funds holding
Funds holding: 35 → 41 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
MYDA Advisors
Woodmere,
New York
|
+$4.05M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
+$3.19M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$1.98M |
| 4 |
ESCM
Echo Street Capital Management
New York
|
+$1.73M |
| 5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$987K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NRCM
Northern Right Capital Management
Darien,
Connecticut
|
-$291K |
| 2 |
CAC
Cowen and Company
New York
|
-$243K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$84K |
| 4 |
LA
Linden Advisors
New York
|
-$64.1K |
FLAC Hedge Fund Activity: Q2 2021 in Review
41 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q2 2021, worth a combined $63.6M — up 27% from $50M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new FLAC positions and 3 closed out — a net gain of 6 holders — while 9 added to existing stakes and 1 trimmed.
The largest buyer was MYDA Advisors, opening a new position worth an estimated $4.05M. The largest seller was Northern Right Capital Management, exiting entirely with an estimated $291K sold.
- 41 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q2 2021, up from 35 in Q1 2021.
- Funds reported $63.6M of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q2 2021, up 27% quarter-over-quarter.
- 9 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q2 2021 and 3 closed out, a net change of +6 holders.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares buyer in Q2 2021 was MYDA Advisors, an estimated $4.05M added.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares seller in Q2 2021 was Northern Right Capital Management, an estimated $291K sold.
Based on aggregated 13F filings for Q2 2021.